Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1mm RC, SLA? 8mm, Ti, Loxim: medical device reports filed with FDA

4,131 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,131
device reports naming the brand
0% of all MAUDE reports · about 605 a year
804
reports, 12 months to August 2026
915 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,131 medical device reports received by FDA name the brand "BL, ? 4.1mm RC, SLA? 8mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

804 reports arrived in the 12 months to August 2026, down 12% from 915 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (88.2%), loss of osseointegration (10.5%) and fracture (0.7%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0129258Sep 2021: 36Oct 2021: 45Nov 2021: 28Dec 2021: 262022Jan 2022: 42Feb 2022: 33Mar 2022: 40Apr 2022: 42May 2022: 25Jun 2022: 22Jul 2022: 28Aug 2022: 19Sep 2022: 31Oct 2022: 38Nov 2022: 58Dec 2022: 352023Jan 2023: 20Feb 2023: 8Mar 2023: 20Apr 2023: 62May 2023: 81Jun 2023: 92Jul 2023: 100Aug 2023: 69Sep 2023: 43Oct 2023: 83Nov 2023: 93Dec 2023: 1042024Jan 2024: 66Feb 2024: 90Mar 2024: 73Apr 2024: 117May 2024: 78Jun 2024: 68Jul 2024: 68Aug 2024: 76Sep 2024: 98Oct 2024: 42Nov 2024: 66Dec 2024: 912025Jan 2025: 61Feb 2025: 50Mar 2025: 75Apr 2025: 44May 2025: 0Jun 2025: 258Jul 2025: 49Aug 2025: 81Sep 2025: 98Oct 2025: 73Nov 2025: 90Dec 2025: 842026Jan 2026: 56Feb 2026: 57Mar 2026: 58Apr 2026: 42May 2026: 39Jun 2026: 65Jul 2026: 95Aug 2026: 47

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04829632019: 10520192020: 14820202021: 33520212022: 41320222023: 77520232024: 93320242025: 96320252026: 4592026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,131
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.5%4,069
Voluntary report0%0
User facility report0%0
Distributor report1.5%62
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,64288.2%62.8%
Loss of osseointegration43210.5%22.4%
Fracturea broken bone280.7%1.6%
Difficult to insertthe device was hard to insert80.2%0.4%
Defective devicethe device was defective10%0%
Separation failure10%0.1%
Unintended movement10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis64615.6%
Painpain, site not specified3298%
Inflammationinflammation2546.1%
Tissue damage1794.3%
Hemorrhage/blood loss/bleeding1202.9%
Swelling/ edema1172.8%
Fistula360.9%
Numbnessnumbness310.8%
Abscessa collection of pus280.7%
Hyperresponsive to stimuli170.4%
Failure of implant120.3%
Inadequate osseointegration100.2%
Hypersensitivity/allergic reaction80.2%
Swellingswelling60.1%
Increased sensitivity50.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1mm RC, SLA? 8mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports4,1313,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1mm RC, SLA? 8mm, Ti, Loxim reports

How many FDA reports name BL, ? 4.1mm RC, SLA? 8mm, Ti, Loxim?

4,131 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 804 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (88.2%), loss of osseointegration (10.5%), fracture (0.7%), difficult to insert (0.2%) and defective device (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.5%) and distributor reports (1.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1mm RC, SLA? 8mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.